Search

Your search keyword '"Karl Ulrich Petry"' showing total 35 results

Search Constraints

Start Over You searched for: Author "Karl Ulrich Petry" Remove constraint Author: "Karl Ulrich Petry" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
35 results on '"Karl Ulrich Petry"'

Search Results

1. Significant decline of HPV 6 infection and genital warts despite low HPV vaccination coverage in young women in Germany: a long-term prospective, cohort data analysis

2. Surgical staging identified false HPV-negative cases in a large series of invasive cervical cancers

3. Estimation of the individual residual risk of cervical cancer after vaccination with the nonavalent HPV vaccine

4. Evidenz‐ und konsensbasierte (S3) Leitlinie: Impfprävention HPV‐assoziierter Neoplasien

5. German evidence and consensus‐based (S3) guideline: Vaccination recommendations for the prevention of HPV‐associated lesions

6. Significant decline of HPV 6 infection and genital warts despite low HPV vaccination coverage in young women in Germany: a long-term prospective, cohort data analysis

7. Evaluation of Integrated HPV DNA as Individualized Biomarkers for the Detection of Recurrent CIN2/3 during Post-Treatment Surveillance

8. Determinants of Human Papillomavirus Vaccine Uptake by Adult Women Attending Cervical Cancer Screening in 9 European Countries

9. FAM19A4/miR124-2 methylation in invasive cervical cancer: A retrospective cross-sectional worldwide study

10. Association of genomic variants at the human leukocyte antigen locus with cervical cancer risk, HPV status and gene expression levels

11. Diagnostik und Therapie der Syphilis : Aktualisierung der S2k-Leitlinie 2020 der Deutsche STI-Gesellschaft (DSTIG) in Kooperation mit folgenden Fachgesellschaften: DAIG, dagnä, DDG, DGA, DGGG, DGHM, DGI, DGN, DGPI, DGU, RKI

12. Incomplete excision of cervical precancer as a predictor of treatment failure: a systematic review and meta-analysis

13. Steep decline of HPV 6 and genital warts despite low HPV vaccination coverage in young women in Germany: a long-term, population-based cohort study

14. Intra- and inter-laboratory agreement of the FAM19A4/mir124-2 methylation test:Results from an international study

15. p53 and p16 expression profiles in vulvar cancer: a translational analysis by the Arbeitsgemeinschaft Gynäkologische Onkologie Chemo and Radiotherapy in Epithelial Vulvar Cancer study group

16. An estimate of the public health impact and cost-effectiveness of universal vaccination with a 9-valent HPV vaccine in Germany

17. Evaluating HPV‐negative CIN2+ in the ATHENA trial

18. Development of a novel enzyme-linked immunosorbent assay for the detection of cytokeratins 5, 8, and 18, and its implications in cervical cancer screening standardization

19. Estimation of the individual residual risk of cervical cancer after vaccination with the nonavalent HPV vaccine

20. Utility of EFC quality indicators for colposcopy in daily practice: results from an independent, prospective multicenter trial

21. Utility and Reproducibility of the International Federation for Cervical Pathology and Colposcopy Classification of Transformation Zones in Daily Practice

22. Sustained Immunogenicity of 2-dose Human Papillomavirus 16/18 AS04-adjuvanted Vaccine Schedules in Girls Aged 9-14 Years: A Randomized Trial

23. Abstract CT209: Safety, efficacy and immunogenicity of VB10.16, a therapeutic DNA vaccine targeting human papillomavirus (HPV) 16 E6 and E7 proteins for high grade cervical intraepithelial neoplasia (CIN 2/3): 6-month data from an exploratory open-label phase I/2a trial

24. A model to evaluate the costs and clinical effectiveness of human papilloma virus screening compared with annual papanicolaou cytology in Germany

30. HPV-FASTER: broadening the scope for prevention of HPV-related cancer

31. Use of the nonavalent HPV vaccine in individuals previously fully or partially vaccinated with bivalent or quadrivalent HPV vaccines

32. LION-PAW: Lymphadenectomy in ovarian neoplasm-pleasure ability of women—Prospective substudy of the randomized multicenter LION study

33. Why follow-back studies should be interpreted cautiously: The case of an HPV-negative cervical lesion

34. Corrigendum to 'Use of the nonavalent HPV vaccine in individuals previously fully or partially vaccinated with bivalent or quadrivalent HPV vaccines' [Vaccine 34 (2016) 757–761]

35. Colposcopy training and assessment across the member countries of the European Federation for Colposcopy

Catalog

Books, media, physical & digital resources